Company: RVRC
Filing Date: 2025-10-03
Form Type: S-1/A
Source: 0001213900-25-096094
Chunk: 206

Company: Revium Rx.
Filing Date: 2025-10-03
Form: S-1/A
Chunk 206
---
about the effective tax rate reconciliation as well as information on income taxes paid. The guidance will be effective for the Company
for annual periods beginning January 1, 2025, with early adoption permitted. The Company is currently evaluating the impact on its financial
statement disclosures.

In November
2024, the FASB issued ASU 2024-03 “Income Statement (Topic 220): Reporting Comprehensive Income - Expense Disaggregation Disclosures” (“ASU
2024-03”), which requires more detailed information about specified categories of expenses presented on the face of the income statement,
in addition to disclosures about selling expenses. ASU 2024-03 is effective for fiscal years beginning after December 15, 2026, with early
adoption permitted. The amendment may be applied either prospectively to financial statements issued for reporting periods after the effective
date or retrospectively to all prior periods presented in the financial statements. The Company is currently evaluating ASU 2024-03 to
determine the impact it may have on its consolidated financial statements and related disclosures.

<div align='center'>F-16</div>

REVIUM RX.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

U.S. dollars in thousands

NOTE 2 – SIGNIFICANT ACCOUNTING POLICIES (Cont.)

Predecessor:

The Financial
Statements have been prepared in accordance with accounting principles generally accepted in the United States (“U.S. GAAP”).

| a. | Use of estimates in preparation of Financial Statements: |

The preparation
of Financial Statements in conformity with U.S. GAAP requires management to make estimates, judgments and assumptions that affect
the amounts reported in the consolidated Financial Statements and accompanying notes. The Company evaluates on an ongoing basis its assumptions.
The Company’s management believes that the estimates, judgments and assumptions used are reasonable based upon information available
at the time they are made. These estimates, judgments and assumptions can affect the reported amounts of assets and liabilities and disclosure
of contingent assets and liabilities at the dates of the consolidated Financial Statements, and the reported amounts of expenses during
the reporting periods. Actual results could differ from those estimates.

As applicable
to the Financial Statements, the most significant estimates and assumptions relate to the going concern assumptions and determining the
fair value of options to granted to the Company’s employee is considered substantial.

| b. | Functional currency: |

The functional
currency of the Company and the presentation currency of the financial statements is the U.S. dollar.

Transactions